Results

Total Results: 552 records

Showing results for "days".

1. Patient Health Questionnaire (PHQ-9) (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/sDvjG49sFm7t3f3CnZUuFw
   October 04, 2005 - For every : Several days = 1 More than half the days = 2 Nearly every day = 3 3. … Scoring: add up all checked boxes on PHQ-9 For every Not at all = 0; Several days = 1; More than … half the days = 2; Nearly every day = 3 Interpretation of Total Score Total Score Depression

2. Behavioral Counseling Interventions: An Evidence-based Approach - Table 1 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/behavioral-counseling-interventions-an-evidence-based-approach---table-1
   November 01, 2013 - level 24 34 34 12 12 12 Current tobacco use by youth (past 30 days … 39 16 3 11 20 6 Youth (12-17) using marijuana in the last 30 days … e  Moderate activity of 30 minutes a day 5 or more days a week.

3. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
   March 15, 2005 - of 20 days. … 7 days. … Lesions from recurrent infections are present for approximately 7 days with viral shedding for 4 days … , 2 week washout, followed by 70 days of placebo, or reverse order DB RCT, with crossover 140 days … Subclinical shedding occurred on 6.9% of days in placebo women and 0.3% of days in treatment women (

4. Screening for Genital Herpes Simplex: A Brief Update (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
   March 01, 2005 - of 20 days. … Viral shedding lasts an average of 12 days and ceases before complete resolution of lesions, if present … 7 days. … Lesions from recurrent infections are present for approximately 7 days with viral shedding for 4 days … Median time to recurrence was 222 to 336 days for famciclovir groups compared with 47 days for the placebo

5. Recommendation: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening
   February 02, 2021 - the ipsilateral carotid artery and no symptoms referable to the contralateral artery for the past 45 days … trial (n = 316) found no difference between groups in the composite outcome of stroke or death at 30 days … trials (n = 3435) found that 2.4% (95% CI, 1.7%-3.1%) of patients died or had a stroke within the 30 days … 8 One cohort study found that 3.8% (95% CI, 2.9%-5.1%) of patients had a stroke or died within 30 days … , 9 In the SPACE-2 trial, 2.5% of patients who underwent CAS or CEA died or had a stroke within 30 days

6. Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/e6_WqcwDGhgT6bQfmk3Hqj
   February 02, 2021 - the ipsilateral carotid artery and no symptoms referable to the contralateral artery for the past 45 days … trial (n = 316) found no difference between groups in the composite outcome of stroke or death at 30 days … were no sig- nificant differences between groups in the composite outcome of stroke or death at 30 days … trials (n = 3435) found that 2.4% (95% CI, 1.7%-3.1%) of patients died or had a stroke within the 30 days … .7,9 In the SPACE-2 trial, 2.5% of patients who underwent CAS or CEA died or had a stroke within 30 days

7. Ad-Br2Otj67Fendhhkltpa (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/aD-Br2oTJ67FeNdHHkLtPA
   weekly or less ss ss ss or Fewer than 3 days … in a rowFewer than 3 days in a rowFewer than 3 days in a rowFewer than 3 days in a row Brief … than once per week More than once per week More than once per week or 3 or more days … in a row 3 or more days in a row 3 or more days in a row 3 or more days in a row Further assessment … Daily or almost daily:Daily or almost daily:Daily or almost daily:Daily or almost daily: 5 to 7 days

8. Final Evidence Summary: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
   June 09, 2020 - 1.24 to 2.13]; absolute risk difference [ARD], 9% [95% CI, 5% to 15%]) and reduced number of drug use days … (19 trials, n = 5085; mean difference, –0.49 day in the last 7 days [95% CI, –0.85 to –0.13]) vs no … Drug use days were standardized to the number of days of drug use during the past 7 days. … Three studies reported the mean number of days of heroin use during the last 30 days, ranging from 19 … to 30 days.

9. Screening for HIV: Clinical Summary of USPSTF Recommendation (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/N4xvbc_aB44m95EL6TztxQ
   Conventional HIV test results are available within 1 to 2 days from most commercial laboratories.

10. Archived: Evidence Summary: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary11/asymptomatic-bacteriuria-in-adults-screening-2008
    July 15, 2008 - Patients in the placebo group averaged 34 days of antibiotic use per 1000 days of follow-up, compared … with 158 days of antibiotic use per 1000 days of follow-up in the treatment group.

11. Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
    July 01, 2008 - Patients in the placebo group averaged 34 days of antibiotic use per 1000 days of follow-up, compared … with 158 days of antibiotic use per 1000 days of follow-up in the treatment group.

12. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
    June 09, 2020 - 1.24 to 2.13]; absolute risk difference [ARD], 9% [95% CI, 5% to 15%]) and reduced number of drug use days … (19 trials, n = 5085; mean difference, –0.49 day in the last 7 days [95% CI, –0.85 to –0.13]) vs no … Drug use days were standardized to the num- ber of days of drug use during the past 7 days. … Three studies re- ported the mean number of days of heroin use during the last 30 days, ranging from … 19 to 30 days.

13. Archived: Evidence Summary: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
    September 25, 2012 - years 35 , 36 , 43  and also show improvement for some utilization outcomes, such as fewer hospital days … but the range of reduction was 1.2– 4.1 drinks/wk at 12 mo (moderate strength); for heavy drinking days … a Baseline heavy drinking days for young adults/college students, about 6–7 heavy drinking days over … Insufficient   Insufficient Utilization outcomes Hospitalization Fewer hospital days … 91 vs. 146 d, and 420 vs. 664 d, respectively; all P < 0.05 § Low Insufficient Fewer hospital days

14. Archived: Final Evidence Review: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review11/asymptomatic-bacteriuria-in-adults-screening-2008
    July 15, 2008 - Patients in the placebo group averaged 34 days of antibiotic use per 1000 days of follow-up, compared … with 158 days of antibiotic use per 1000 days of follow-up in the treatment group.

15. Archived: Tobacco Use in Children and Adolescents: Primary Care Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-children-and-adolescents-primary-care-interventions-2013
    August 15, 2013 - nonsmokers (defined as never smoking—not even 1 puff) who reported ever smoking (even 1 puff) in the past 30 days … tobacco use or having ever used tobacco more than 100 times) who reported tobacco use in the past 30 days … One study reported the percentage of baseline nonsmokers (no smoking in the past 30 days) who reported … smoking 1 or more cigarettes in the past 30 days at posttest.

16. Evidence Summary: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/abdominal-aortic-aneurysm-screening
    December 10, 2019 - In addition, the percentage of patients with any morbidity related to repair at 30 days was also higher … e Defined as hospital death or death within 30 days of surgery. … f Reinterventions 30 or fewer days after surgery; for 30 or more days after surgery, 50 patients underwent … g Endoleak on follow-up imaging 30 or more days after procedure. … i Defined as hospital death or death within 30 days of surgery.

17. Archived: Problem Drinking: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/problem-drinking-screening-1996
    January 01, 1996 - decreased alcohol consumption) in treated versus control subjects 73-76 counseling reduced reported sick days … 19%). 93 In the second, men receiving naltrexone reported less alcohol craving and fewer drinking days … Antabuse) did not improve long-term abstinence rates in a controlled trial, but it did reduce drinking days

18. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - meta-analysis of primary and secondary prevention trials testing daily aspirin use for more than 90 days … The WHS ( n = 39,876) found no effect on CRC mortality with very-low-dose aspirin taken on alternate days

19. Archived: Evidence Summary: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/genital-herpes-screening-november-2016
    December 20, 2016 - In the RCT assessing valacyclovir (n = 63), valacyclovir treatment significantly reduced subclinical days … 1.5% vs 5.1%, P < 0.001) and also resulted in a greater proportion of participants experiencing no days … Participants with any shedding, No. (%), Group 1: 27 (42.9) Group 2: 29 (50.0) P = NR Days … RCTs The valacyclovir trial found that those taking valacyclovir (1 g daily) had fewer subclinical days … The famciclovir trial found that those taking famciclovir (250 mg twice daily) had fewer subclinical days

20. Procedure Manual Section 7. Formulation of Task Force Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-7-formulation-task-force-recommendations
    June 21, 2025 - The Chair then calls for a vote (which may take place via conference call or email after several days … The Chair then calls for a vote on the motion (which may take place via email after several days of reflection